Program Schedule


Asia Pacific Health Care Compliance Program

 

Asia-Pacific Healthcare Compliance Certificate Program

[email protected] | 973-642-8871

PROGRAM SCHEDULED for Sept. 20 - 23, 2021 | Singapore
Capacity: 40 | Language: English
 

 

This schedule is representative of a previous Program's agenda and is posted here for sample purposes only. The final program agenda will be posted sixty days before the Program's start.
All times are local time in Singapore.
DAY 1

09:00-09:10

Welcome & Format Review

09:15-10:10

Aligning the “Why” and “How” of Compliance
Professor Timothy Glynn, Seton Hall Law School (New Jersey)

10:15-11:15

Session TBD

11:15-11:30

Break

11:30-12:25

Global Anti-Corruption Enforcement
Wilson Ang,Norton Rose Fulbright (Singapore)
Orlando Vidal, Norton Rose Fulbright (Dubai)

12:30-13:15

Being the Focus of a Government Investigation
Yuet Ming Tham, Sidley Austin LLP (Hong Kong/Singapore)

DAY 2

Optional

Competition Law in Pharmaceutical & Medical Device Sectors with Korea Focus
Hwa-Soo Chung, Kim & Chang (Seoul)

Optional

China Healthcare Compliance Update
Eric Carlson, Covington & Burling LLP (Shanghai)
Ping An, Covington & Burling LLP (Shanghai)

09:00-09:30

Anti-Corruption Settlements
Eric Carlson, Covington & Burling LLP (Shanghai)
Ping An, Covington & Burling LLP (Shanghai)

09:35-10:45

Panel Discussion: Pharma & Device Industry Codes: How Key Interactions are Regulated Under IFPMA, APACMed & Korean Codes; Asia Transparency Trends & Challenges
Hwa-Soo Chung, Kim & Chang (Seoul)
Lucas Nicolet-Serra, Simmons & Simmons LLP (Singapore)

10:50-11:20

COVID-19 Session
Jennifer Oliva, Seton Hall Law School (New Jersey)

11:20-11:35

Break

11:35-12:15

How to Be Recognized as a Trusted Compliance Professional
Young Sang Kwon, Johnson & Johnson (Singapore)

12:20-13:35

Compliance Officers Panel Discussion
Maija Burtmanis, Senior Legal/Compliance Life Sciences Executive (Japan)
Stephanie Chew, Edwards Lifesciences (Shanghai)
Ronald Goon, formerly of Johnson & Johnson (Singapore)
Paul Sumilas, Zimmer Biomet (Singapore)
Moderator: Timothy Glynn, Seton Hall Law School (New Jersey)

13:35-13:45

Case Study Assignments

DAY 3

Optional

Health Care in India: Regulatory Compliance— Prevention is Better Than a Cure
Dr. Milind Antani, Nishith Desai Associates (Mumbai)
Darren Punnen, Nishith Desai Associates (Mumbai)

09:00-09:30

Clinical Trials
Carl Coleman, Seton Hall Law School (New Jersey)

09:35–10:05

Emerging Risk Area—Legal and Compliance Overview of Patient Programs
Maija Burtmanis, Senior Legal/Compliance Life Sciences Executive (Japan)

10:05-10:30

Interactive Session on Hot Topics in Patient Programs
Maija Burtmanis, Senior Legal/Compliance Life Sciences Executive (Japan)

10:30-10:40

Break

10:40-11:25

Assessing Third-Party Risk
Red Romero, Vifor Pharma Asia Pacific Pte. Ltd. (Singapore)

11:30-12:15

Building an Effective Compliance Program and Team
Stephanie Chew, Edwards Lifesciences (Shanghai)

12:15-12:30

Break

12:30-15:00

Case Study Workshop

DAY 4

09:00-09:30

A Journey to the Dark Side of International Business: Real-World RIsk and Real-World Lessons--Ask Richard
Richard Bistrong, Front-Line Anti-Bribery LLC (Connecticut)

09:35 - 10:15

Data Analytics
Lem Chin Kok, KPMG (Singapore)

10:20-10:45

Data Protection Risks as Related to Anti-Corruption Compliance, Mergers & Acquisitions, and Internal Investigations
Ken Chia, Baker & McKenzie, Wong & Leow LLC (Singapore)

10:45-11:00

Break

11:00-12:30

Interactive Session--Part 2: Team Presentations & Classroom Discussion
Ronald Goon Formerly of Johnson & Johnson (Singapore)

12:30-12:45

Closing Remarks/End of Program


Celebrating 15 years in Compliance



Learn more about our programs.